ArticleBMC cancer2026
Improving access and uptake of lung cancer screening with a focus on health inequity: the views of professionals involved in the UK NHS lung cancer screening programme.
Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThere is strong evidence that targeted lung cancer screening is effective, but equitable access remains essential to prevent widening health disparities. This study examines the views of professional stakeholders involved in the design and delivery of the UK NHS Lung Cancer Screening Programme (LCSP) with a particular focus on access, uptake and health inequity.
methodsIndividual semi-structured interviews were conducted with twenty-one professionals involved in the set-up or delivery of LCSP services across England. Data collection took place between May and August 2024. Data were analysed inductively using reflexive thematic analysis.
resultsProfessionals’ views centred on three themes: (1) Constructing the screening population: identifying eligible individuals for screening related to the accuracy of primary care data, decisions around individuals’ fitness-to-participate and monitoring population uptake; (2) From invitation to participation: design and delivery of screening could differ across services with implications for understanding requirements of screening, decision-making and participation; (3) Raising the profile of lung cancer screening: greater coordination between local networks, teams and service providers was viewed as essential to support awareness, access and uptake.
conclusionsEnsuring equitable lung cancer screening access requires coordinated strategies across the screening pathway, including improved data collection, clearer clinical guidance, greater understanding of population engagement and more awareness across stakeholder groups. Addressing equity-related factors is crucial to ensuring access and uptake of the LCSP as it expands into a population-wide programme across England by 2030.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.